- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers: A Feasible Technology in Cancer Immunotherapy
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2016, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2016-06-21
DOI
10.1155/2016/1083738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting inhibition of Foxp3 by a CD28 2′-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy
- (2016) Teresa Lozano et al. BIOMATERIALS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
- (2016) David T. Rodgers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aptamers: A promising chemical antibody for cancer therapy
- (2016) Gang Zhou et al. Oncotarget
- MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
- (2016) Mario Martínez Soldevilla et al. Oncotarget
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
- (2015) J. Naidoo et al. ANNALS OF ONCOLOGY
- 2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia
- (2015) Mario Martinez Soldevilla et al. BIOMATERIALS
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment
- (2015) Agata Levay et al. NUCLEIC ACIDS RESEARCH
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
- (2015) Dominik Oberthür et al. Nature Communications
- Identification of TIM3 2’-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy
- (2015) Sandra Hervas-Stubbs et al. Oncotarget
- Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery
- (2015) E. Gilboa et al. Cancer Immunology Research
- Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
- (2015) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
- (2015) Chang Ho Lee et al. Molecular Therapy-Nucleic Acids
- Reducing toxicity of 4–1BB costimulation: targeting 4–1BB ligands to the tumor stroma with bi-specific aptamer conjugates
- (2015) B Schrand et al. OncoImmunology
- 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity
- (2015) Todd Bartkowiak et al. Frontiers in Oncology
- Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
- (2015) Elizabeth D. Pratico et al. Nucleic Acid Therapeutics
- Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor
- (2014) Shashi Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
- (2014) Andreas Herrmann et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Aptamer-targeted Antigen Delivery
- (2014) Brian C Wengerter et al. MOLECULAR THERAPY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
- (2014) John C Rohloff et al. Molecular Therapy-Nucleic Acids
- Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
- (2013) E. Gilboa et al. CLINICAL CANCER RESEARCH
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
- (2013) Alexey Berezhnoy et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Hepatitis C Virus (HCV) Replication by Specific RNA Aptamers against HCV NS5B RNA Replicase
- (2013) C. H. Lee et al. JOURNAL OF VIROLOGY
- A Novel C5a-neutralizing Mirror-image (l-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis
- (2013) Kai Hoehlig et al. MOLECULAR THERAPY
- Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells
- (2013) Jiehua Zhou et al. NUCLEIC ACIDS RESEARCH
- Ipilimumab
- (2013) Drugs in research & development
- CD28 Aptamers as Powerful Immune Response Modulators
- (2013) Fernando Pastor et al. Molecular Therapy-Nucleic Acids
- A Short DNA Aptamer That Recognizes TNFα and Blocks Its Activity in Vitro
- (2012) Erik W. Orava et al. ACS Chemical Biology
- PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice
- (2012) Chiara Da Pieve et al. BIOCONJUGATE CHEMISTRY
- Aptamer-Mediated Blockade of IL4R Triggers Apoptosis of MDSCs and Limits Tumor Progression
- (2012) F. Roth et al. CANCER RESEARCH
- Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents
- (2012) K. M. Bompiani et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Therapeutic RNA aptamers in clinical trials
- (2012) Padma Sundaram et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Isolation and Optimization of Murine IL-10 Receptor Blocking Oligonucleotide Aptamers Using High-throughput Sequencing
- (2012) Alexey Berezhnoy et al. MOLECULAR THERAPY
- Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells
- (2012) Cindy Meyer et al. RNA Biology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
- (2011) E. J. Lipson et al. CLINICAL CANCER RESEARCH
- Chimeric aptamers in cancer cell-targeted drug delivery
- (2011) Jagat R. Kanwar et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Bi-specific Aptamers Mediating Tumor Cell Lysis
- (2011) Achim Boltz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PEGylated Anti-MUC1 Aptamer-Doxorubicin Complex for Targeted Drug Delivery to MCF7 Breast Cancer Cells
- (2011) Lihan Tan et al. MACROMOLECULAR BIOSCIENCE
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
- (2011) Fernando Pastor et al. MOLECULAR THERAPY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals
- (2010) Erik W. Orava et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
- (2010) N. Casares et al. JOURNAL OF IMMUNOLOGY
- Naptumomab Estafenatox, an Engineered Antibody-superantigen Fusion Protein With Low Toxicity and Reduced Antigenicity
- (2010) Göran Forsberg et al. JOURNAL OF IMMUNOTHERAPY
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
- (2010) Petra Paulinska et al. THROMBOSIS AND HAEMOSTASIS
- Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy
- (2009) M. Kortylewski et al. CANCER RESEARCH
- In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
- (2009) Marcin Kortylewski et al. NATURE BIOTECHNOLOGY
- Development of universal antidotes to control aptamer activity
- (2009) Sabah Oney et al. NATURE MEDICINE
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer
- (2008) Claudia M. Dollins et al. CHEMISTRY & BIOLOGY
- Diabodies Targeting Epithelial Membrane Protein 2 Reduce Tumorigenicity of Human Endometrial Cancer Cell Lines
- (2008) K. Shimazaki et al. CLINICAL CANCER RESEARCH
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
- (2008) James O. McNamara et al. JOURNAL OF CLINICAL INVESTIGATION
- Nonsense-Mediated mRNA Decay Impacts MSI-Driven Carcinogenesis and Anti-Tumor Immunity in Colorectal Cancers
- (2008) Jamila El-Bchiri et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search